Show simple item record

dc.contributor.authorWidjaja, Nicole
dc.date.accessioned2020-05-14T17:55:13Z
dc.date.available2020-05-14T17:55:13Z
dc.date.issued2020-05
dc.identifier.urien
dc.identifier.urihttp://hdl.handle.net/10675.2/623359
dc.description.abstractNorovirus is a highly infectious, non-enveloped virus found to be the leading cause of global gastroenteritis outbreaks. Every year within the United States, this virus is responsible for an average of 19-21 million cases of acute gastroenteritis, approximately 570-800 deaths, and has been the cause of 1.7 to 1.9 million outpatient visits. On a global scale, healthcare costs and lost productivity are estimated to $60 billion due to illnesses and outbreaks caused by the burden of norovirus. Unfortunately, current measures to prevent the transmission of norovirus remain insufficient as the Center for Disease Control and Prevention (CDC) can only recommend hand washing with soap and water as the best preventative measure. The only other hand hygiene method available is alcohol-based hand sanitizers, but the CDC states that they are not effective in inactivating norovirus particles and warns that it should not be considered a substitute to hand washing. Recently, epigallocatecin-3-gallate (EGCG) a major component extracted from the leaves of Camellia sinensis, also commonly known as tea plant, has shown potential to be the next viable candidate as an antiviral solution. Lipid derivatives of EGCG, most notably EGCGpalmitate, has shown to express potent antiviral properties and has showed to play a crucial role in the fight against other non-enveloped viruses such as poliovirus and adenovirus. In this study, we determined the efficacy of EGCG-palmitate in novel formulations against human norovirus surrogates by utilizing the EU international standards for hand hygiene in vitro studies against norovirus. Evidence is provided determining the virucidal activity of alcohol-based ProtecTeaV formulations containing EGCG-palmitate as well as the potential for EGCG-palmitate as a persistent residual virucidal activity against norovirus surrogates, feline calicivirus (FCV) and murine norovirus-1 (MNV-1). By creating an effective, environmentally friendly, non-toxic and long lasting solution composed of EGCG-palmitate, the results of this innovative approach would expand the options available to reduce the transmission of norovirus essentially bridging the gap for a new preventative hand hygiene and ultimately impacting the spread of norovirus on a worldwide scale.en_US
dc.publisherAugusta University
dc.rightsCopyright protected. Unauthorized reproduction or use beyond the exceptions granted by the Fair Use clause of U.S. Copyright law may violate federal law.en_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectNorovirus, EGCG-palmitate, Hand sanitizer, Hand hygieneen_US
dc.titleEfficacy of Epigallocatechin-3-gallate-palmitate as a Virucidal Compound Against Norovirusen_US
dc.typeThesisen_US
dc.typeThesisen
dc.contributor.departmentDepartment of Oral Biology and Diagnostic Sciencesen_US
dc.description.advisorStephen Hsuen_US
dc.description.degreeM.S.en_US
dc.description.majorMaster of Science in Oral Biologyen_US
dc.description.committeeArjunan, Pachiappan; Messer, Regina; Teng, Yongen_US
refterms.dateFOA2020-05-14T17:55:14Z


Files in this item

Thumbnail
Name:
widjaja_MS.pdf
Size:
2.337Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright protected. Unauthorized reproduction or use beyond the exceptions granted by the Fair Use clause of U.S. Copyright law may violate federal law.
Except where otherwise noted, this item's license is described as Copyright protected. Unauthorized reproduction or use beyond the exceptions granted by the Fair Use clause of U.S. Copyright law may violate federal law.